259 related articles for article (PubMed ID: 24659319)
1. The use of molecular genetics to refine prognosis in acute myeloid leukemia.
Bhatnagar B; Garzon R
Curr Hematol Malig Rep; 2014 Jun; 9(2):148-57. PubMed ID: 24659319
[TBL] [Abstract][Full Text] [Related]
2. Are results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?
Rao AV; Smith BD
Curr Hematol Malig Rep; 2013 Jun; 8(2):149-55. PubMed ID: 23595294
[TBL] [Abstract][Full Text] [Related]
3. Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia.
Heo SG; Koh Y; Kim JK; Jung J; Kim HL; Yoon SS; Park JW
BMC Med Genet; 2017 Mar; 18(1):23. PubMed ID: 28249600
[TBL] [Abstract][Full Text] [Related]
4. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.
Ziai JM; Siddon AJ;
Am J Clin Pathol; 2015 Oct; 144(4):539-54. PubMed ID: 26386075
[TBL] [Abstract][Full Text] [Related]
5. Recent discoveries in molecular characterization of acute myeloid leukemia.
Khasawneh MK; Abdel-Wahab O
Curr Hematol Malig Rep; 2014 Jun; 9(2):93-9. PubMed ID: 24609756
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
Jongen-Lavrencic M; Sun SM; Dijkstra MK; Valk PJ; Löwenberg B
Blood; 2008 May; 111(10):5078-85. PubMed ID: 18337557
[TBL] [Abstract][Full Text] [Related]
7. Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.
Walker A; Marcucci G
Expert Rev Hematol; 2012 Oct; 5(5):547-58. PubMed ID: 23146058
[TBL] [Abstract][Full Text] [Related]
8. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
Falini B; Martelli MP
Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
[TBL] [Abstract][Full Text] [Related]
9. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
10. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Roloff GW; Griffiths EA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):35-44. PubMed ID: 30504289
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
12. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
Bullinger L; Ehrich M; Döhner K; Schlenk RF; Döhner H; Nelson MR; van den Boom D
Blood; 2010 Jan; 115(3):636-42. PubMed ID: 19903898
[TBL] [Abstract][Full Text] [Related]
13. Molecular signatures in acute myeloid leukemia.
Mrózek K; Radmacher MD; Bloomfield CD; Marcucci G
Curr Opin Hematol; 2009 Mar; 16(2):64-9. PubMed ID: 19468266
[TBL] [Abstract][Full Text] [Related]
14. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
15. Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.
Lin TL; Smith BD
Am J Med Sci; 2011 May; 341(5):404-8. PubMed ID: 21522052
[TBL] [Abstract][Full Text] [Related]
16. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
17. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
18. [Molecular Genetic Testing for Acute Myeloid Leukemia].
Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
